| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/04/2010 | CN101792414A Method for preparing 2-(3'-quinolyl) propenol |
| 08/04/2010 | CN101148448B Method for preparing N2-quinoline substituted purine derivative |
| 08/03/2010 | US7767818 Hepatitis C inhibitor dipeptide analogs |
| 08/03/2010 | US7767817 Water soluble boronic acid fluorescent reporter compounds and methods of use thereof |
| 08/03/2010 | US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/03/2010 | US7767672 Aminopyrimidines useful as kinase inhibitors |
| 08/03/2010 | US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators |
| 08/03/2010 | CA2610873C Tetrahydroquinolines and their use as modulators of metabotropic glutamate receptors |
| 08/03/2010 | CA2526228C Quinoline derivatives as phosphodiesterase inhibitors |
| 07/29/2010 | WO2010085525A1 Bridged and fused heterocyclic antidiabetic compounds |
| 07/29/2010 | WO2009158467A3 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors |
| 07/29/2010 | US20100190987 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast |
| 07/29/2010 | US20100190777 Compounds and methods for kinase modulation, and indications therefor |
| 07/29/2010 | US20100190745 Heterocyclic urea derivatives and methods of use thereof |
| 07/29/2010 | US20100188618 Liquid-crystal display |
| 07/28/2010 | EP2210607A1 N-[3-fluoro-4-({6-(methyloxy)-7-[(3-piperidin-1-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer |
| 07/28/2010 | EP2209769A1 Novel crystalline salts of montelukast |
| 07/28/2010 | EP1963271B1 Quinolone m1 receptor positive allosteric modulators |
| 07/28/2010 | CN101790376A Tsh receptor antagonizing tetrahydroquinoline compounds |
| 07/27/2010 | US7763627 2-pyridin-4-ylquinazolin-4- amine's such as N-cyclohexyl-2-pyridin-4-ylquinazolin-4- amine, used as tyrosine kinase inhibitors, for modulating cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion; antiproliferative agents and angiogenesis inhibitors |
| 07/27/2010 | CA2466560C Acetylene derivatives having mglur5 antagonistic activity |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/22/2010 | WO2010083414A1 Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
| 07/22/2010 | WO2010082714A1 Method for efficiently producing montelukast |
| 07/22/2010 | WO2010081900A1 Quinolinone derivatives useful for the treatment of cns disorders |
| 07/22/2010 | WO2009080198A8 Fused cynopryridines and the use thereof |
| 07/22/2010 | WO2009040377A3 Radiolabelled 1, 4 -dihydro-4 -oxo-quinoline 3-carboxylic acid derivatives for pet and spect imaging, and in-vitro detection of the gaba-a receptor |
| 07/22/2010 | US20100185419 Algorithm for designing irreversible inhibitors |
| 07/22/2010 | US20100184986 Sulfonamide-based organocatalysts and method for their use |
| 07/22/2010 | US20100184977 Nickel or Iron Catalysed Carbon-Carbon Coupling Reaction of Arylenes, Alkenes and Alkines |
| 07/22/2010 | US20100184763 Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 07/22/2010 | US20100184741 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/22/2010 | US20100184739 Modulators of ATP-Binding Cassette Transporters |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183563 Dentinogenesis promoter and dentinogenic pulp-capping material |
| 07/22/2010 | CA2758030A1 Malate salt of n-(4-{[6,7-bis(methyloxy)quin0lin-4-yl]oxy}phenyl-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
| 07/21/2010 | CN1968927B Method for enantiomer selective preparation for quinoline derivative |
| 07/21/2010 | CN101784533A 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 07/21/2010 | CN101781313A Method for synthesizing quinolone medicaments |
| 07/21/2010 | CN101781299A One-pot synthesis method for key intermediate of carbostyril medicaments |
| 07/21/2010 | CN101781260A Nitrogen heterocyclic ring series compound and preparation method thereof |
| 07/21/2010 | CN101781247A New method for synthesizing substituted 3-quinoline carboxylic acid and analogue |
| 07/21/2010 | CN101781246A Improved method for synthesizing Aripiprazole |
| 07/20/2010 | US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor |
| 07/20/2010 | US7759362 1-cyclopropyl-8-difluoromethoxyl-7-[(1S,6S)-2,8-diazabicyclo[4,3,0]nonane-8-yl]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride, having potent antibacterial activity against broad-spectrum pathogenic bacteria, with favorable pharmacokinetics and very low toxicity |
| 07/20/2010 | CA2486399C Calcium receptor modulating agents |
| 07/20/2010 | CA2399001C Integrin expression inhibitor |
| 07/15/2010 | WO2010079675A1 Method for manufacturing bicyclic aromatic hydroxycarboxylic acid |
| 07/15/2010 | WO2010057101A3 Compounds useful as hiv blockers |
| 07/15/2010 | US20100179326 Benzamide derivative |
| 07/15/2010 | US20100179325 Compound having 11beta-hsd1 inhibitory activity |
| 07/15/2010 | US20100179177 Heterocyclic compounds and their uses |
| 07/15/2010 | US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold |
| 07/14/2010 | EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 07/14/2010 | EP2205559A1 Renin inhibitors |
| 07/14/2010 | EP2021333B1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 07/14/2010 | EP1824830B1 Radiolabelled quinoline-based ligands for the 5-ht6 receptor functionality |
| 07/14/2010 | CN1823063B Quinoline derivatives as phosphodiesterase inhibitors |
| 07/14/2010 | CN101774968A (E)-N-(5-chlorine-8-hydroxyl-2-styrene quinolyl) phenylsulfonyl aminated compound as well as preparation method and application thereof |
| 07/13/2010 | US7754890 Arylsulfones and uses related thereto |
| 07/13/2010 | US7754886 N-acylsulfonamide apoptosis promoters |
| 07/13/2010 | CA2567776C Vasopressin v1a antagonists |
| 07/13/2010 | CA2374659C N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and agents for treating neurodegenerative diseases comprising the same |
| 07/08/2010 | WO2010077798A2 Stereoselective synthesis of piperidine derivatives |
| 07/08/2010 | WO2010077062A2 Preparation method of statin compound and benzothiazolyl sulfone compound used therein |
| 07/08/2010 | WO2010076764A1 Irreversible egfr inhibitor compounds with antiproliferative activity |
| 07/08/2010 | US20100174083 Method for the preparation of montelukast |
| 07/08/2010 | US20100173917 Urea derivatives as abl modulators |
| 07/08/2010 | US20100173899 Dipeptide analogs as coagulation factor inhibitors |
| 07/08/2010 | US20100171116 Organic metal complexs derivative and organic light emitting device using the same |
| 07/08/2010 | CA2743700A1 Stereoselective synthesis of piperidine derivatives |
| 07/07/2010 | CN1845894B Phenoxiacetic acid derivatives |
| 07/07/2010 | CN101768138A Organic micro-molecular film containing protonized nitrogen atoms and preparation method thereof |
| 07/07/2010 | CN101768114A Synthesis method of 4-substituted-3-fluorine-2-quinolone |
| 07/07/2010 | CN101768113A Method for purifying intermediate of aripiprazole |
| 07/07/2010 | CN101768112A Two-photon induced luminous compound with symmetrical both ends and synthesis method and purposes thereof |
| 07/06/2010 | US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds |
| 07/06/2010 | US7750068 Organic pigment dispersant is sulfonated (8-o-carboxybenzoylamino)-2-(1,3-indanedion-2-yl)quinoline or sulfonated (8-o-carboxybenzoylamino)-2-(o-carboxybenzoylmethyl)quinoline or ammonium or metal salt; pigment carrier may be a copolymer of an alkylene oxide mono(meth)acrylic acid monoalkylphenol adduct |
| 07/06/2010 | CA2427429C Acylaminoalkyl-substituted benzenesulfonamide derivatives,their preparation, their use and pharmaceutical preparations comprising them |
| 07/01/2010 | WO2010075280A2 Coumarin-based compounds |
| 07/01/2010 | WO2010074807A1 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators |
| 07/01/2010 | WO2010073235A1 Ppar agonist compositions and methods of use |
| 07/01/2010 | WO2010072354A1 MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR |
| 07/01/2010 | WO2010042596A3 Photo-activated protecting groups |
| 07/01/2010 | WO2010036329A3 Process for making quinolone compounds |
| 07/01/2010 | US20100168432 Process for the Preparation of Montelukast |
| 07/01/2010 | US20100168161 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
| 07/01/2010 | US20100168114 Invertebrate acetylcholinesterase inhibitors |
| 07/01/2010 | US20100168100 Quinoline derivatives as p13 kinase inhibitors |
| 07/01/2010 | US20100168099 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 07/01/2010 | US20100168065 Quinolinone derivatives as parp and tank inhibitors |
| 07/01/2010 | US20100168064 Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents |
| 07/01/2010 | US20100167927 Substituted Amino-Thiourea Compounds For Combating Animal Pests |
| 07/01/2010 | US20100166706 Hcv ns-3 serine protease inhibitors |
| 07/01/2010 | US20100164371 Electron transporting-injection compound and organic electroluminescent device using the same |
| 07/01/2010 | CA2748124A1 Ppar agonist compositions and methods of use |
| 07/01/2010 | CA2748105A1 Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the .beta.2 adrenergic receptor |
| 07/01/2010 | CA2747811A1 Coumarin-based compounds |
| 06/30/2010 | EP2201964A2 Formoterol superfine formulation |
| 06/30/2010 | EP2201945A2 Substituted 2-Aminoacetamides and the Use Thereof |